Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01549925 · ClinicalTrials.gov registry record · NA
Surgical Trial Comparing LIGASURE Assisted Recto-Sigmoid Resection and Omentectomy Compared to Stand
A NA study of Epithelial Ovarian Cancer, sponsored by University of Utah.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 2
- Study locations
NCT01549925 is a NA study of Epithelial Ovarian Cancer that has completed, run by University of Utah. The registered enrollment target is 50 participants, below the 210-participant average among 41 other Epithelial Ovarian Cancer trials with a reported enrollment target (76% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT01549925, a NA study of Epithelial Ovarian Cancer, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 2
- Study locations
Study Summary
The objective of this prospective randomized surgical trial is to evaluate whether the use of the LIGASURE surgical device during omentectomy and/or recto-sigmoid resection for women with ovarian cancer will reduce the surgical time compared to standard surgical resection using clamps and surgical ligatures.
Conditions Studied
Interventions
- OTHER Standard Surgical resection
- DEVICE LIGASURE
Study Locations (2)
Utah
- Intermountain Health Care - Salt Lake City
- Huntsman Cancer Institute - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2011-01 |
| Est. Completion | 2014-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01549925
The ClinicalTrials.gov registry entry for NCT01549925 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 210-participant average among 41 other Epithelial Ovarian Cancer trials with a reported enrollment target (76% lower). The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Epithelial Ovarian Cancer appearing as the primary indexed condition, and to 2 interventions - of which Standard Surgical resection is the first listed.
NCT01549925 reports 2 study locations spanning 1 distinct geographic area - top geographies include Utah.
Frequently Asked Questions
What is clinical trial NCT01549925 about?
NCT01549925 is a clinical study titled "Surgical Trial Comparing LIGASURE Assisted Recto-Sigmoid Resection and Omentectomy Compared to Stand". The objective of this prospective randomized surgical trial is to evaluate whether the use of the LIGASURE surgical device during omentectomy and/or recto-sigmoid resection for women with ovarian cancer will reduce the surgical time compared to standard surgical resection using clamps and surgical l...
What is the current status of trial NCT01549925?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2011-01. Estimated completion is 2014-09.
What conditions does trial NCT01549925 study?
This clinical trial studies the following conditions: Epithelial Ovarian Cancer.
What interventions are being tested in trial NCT01549925?
The interventions under investigation include: Standard Surgical resection (OTHER), LIGASURE (DEVICE).
Who is sponsoring clinical trial NCT01549925?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01549925 being conducted?
This trial has 2 study locations across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Epithelial Ovarian Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)
RECRUITING · NA
-
Fasting During Neoadjuvant Chemotherapy in Patient With Epithelial Ovarian Cancer
RECRUITING · NA
-
T-regulatory Cell Depletion with E7777 Combined with Pembrolizumab in Recurrent or Metastatic Solid Tumors
RECRUITING · Phase 1
-
Study of AVZO-021 in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
RECRUITING · Phase 3
-
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.